Acadia Pharmaceuticals reported $115.47M in Sales Revenues for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.47M 15.29M
Alnylam Pharmaceuticals ALNY:US $ 213.26M 45.28M
Aptinyx Inc APTX:US $ 0 0
Biomarin Pharmaceutical BMRN:US $ 519.36M 69.55M
Cara Therapeutics CARA:US $ 4.79M 3.97M
Corcept Therapeutics CORT:US $ 98.82M 2.69M
Cytokinetics CYTK:US $ 1.15M 54.45M
Eisai 4523:JP Y 190901M 12071M
Prothena PRTA:US 1.15M 19K
Ultragenyx Pharmaceutical RARE:US $ 79.94M 3.45M